Ronan Kennedy

cbdMD Reduces Operating Loss, Reports Positive Net Income For Q3 And 15% YoY Drop In Net Sales

IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now

cbdMD's Financial Results: Cost-Cutting Measures For Positive Cash Flow Amid Increasing Losses

IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now

cbdMD's Financial Results: Cost-Cutting Measures For Positive Cash Flow Amid Increasing Losses

cbdMD Reports YoY Dip In Q1 Net Sales, Shrinks Operating Loss, Expands Into Hemp And Mushroom Products Markets

Medical Cannabis Pioneer cbdMD Secures $1.2M To Fund Rollout Of Functional Mushroom Products

cbdMD Reports YoY Dip In Q1 Net Sales, Shrinks Operating Loss, Expands Into Hemp And Mushroom Products Markets

Medical Cannabis Pioneer cbdMD Secures $1.2M To Fund Rollout Of Functional Mushroom Products

CBD Giant's Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoY

cbdMD Reports Q3 2023 Performance: Net Loss Improves, Focus On Cost Management & Strategic Growth

Ronan Kennedy Recent News

cbdMD Q2 2023 Results: Net Loss Improves, Costs Plummet

Charlotte-based CBD company cbdMD (AMEX: YCBD) reported its second-quarter fiscal 2023 results late Monday, revealing an improved net loss and significant reductions in selling, general and administrative (SG&A) costs.

cbdMD Expands Its Reach To The United Kingdom With Launch On Amazon UK

cbdMD, Inc. (AMEX:YCBD) launched its novel food validated hemp-derived CBD products on Amazon.co.uk (NASDAQ: AMZN) in the United Kingdom.